Test Bank - Abrams’ Clinical Drug Therapy Rationales for Nursing Practice, 13th Edition (Frandsen, 2025), Chapter 1-61 All Chapters

TEST BANK FOR ABRAMS’ CLINICAL DRUG THERAPY
g g g g g g g


RATIONALES FOR NURSING PRACTICE 12TH EDITION
g g g g g g


GERALYN FRANDSEN
g

,TEST BANK FOR ABRAMS’ CLINICAL DRUG THERAPY
g g g g g g g


RATIONALES FOR NURSING PRACTICE 12TH EDITION
g g g g g g


GERALYN FRANDSEN g




TestgBankgForgAbrams’gClinicalgDruggTherapygRationalesgforgNursinggPracticeg12thgEdition
gGeralyngFrandseng-gISBN/ISSNg9781975136130




TablegofgContent

SECTIONg1gThegConceptualgFrameworkgofgPharmacologygChap

terg1gThegFoundationgofgPharmacology:gQualitygandgSafetygChapterg

2gBasicgConceptsgandgProcesses

Chapterg3gMedicationgAdministrationgandgthegNursinggProcessgofgDruggTherapy



SECTIONg2gDruggTherapygThroughoutgthegLifespan

Chapterg4gPharmacologygandgthegCaregofgInfantsgandgPediatricgPatientsgMedicationgAdministrationgingP
ediatrics

Chapterg5gPharmacologygandgthegCaregofgAdultsgandgGeriatricgPatientsg

Chapterg6gPharmacologygandgthegCaregofgPregnantgorgLactatinggWomang

Chapterg7gPharmacologygandgWomen’sgHealth

Chapterg8gPharmacologygandgMen’sgHealth



SECTIONg3gDrugsgAffectinggthegHematopoieticgandgImmunegSystems

Chapterg9gDruggTherapygforgCoagulationgDisordersgC

hapterg10gDruggTherapygforgDyslipidemia

Chapterg11gDruggTherapygforgHematopoieticgDisorder

sgChapterg12gDruggTherapy:gImmunizations

Chapterg13gDruggTherapygtogDecreasegImmunitygCha

pterg14gDruggTherapygforgthegTreatmentgofgCancer

,TEST BANK FOR ABRAMS’ CLINICAL DRUG THERAPY
g g g g g g g


RATIONALES FOR NURSING PRACTICE 12TH EDITION
g g g g g g


GERALYN FRANDSEN g




SECTIONg4gDrugsgAffectinggInflammationgandgInfection

Chapterg15gInflammation,gInfection,gandgthegUsegofgAntimicrobialgAgent

sgChapterg16gDruggTherapygtogDecreasegPain,gFever,gandgInflammationg

Chapterg17gDruggTherapygWithgCorticosteroids

Chapterg18gDruggTherapygWithgBeta-

LactamgAntibacterialgAgentsgChapterg19gDruggTherapygWithgAminoglyc

osidesgandgFluoroquinolones

Chapterg20gDruggTherapygWithgTetracyclines,gSulfonamides,gandgUrinarygAntisepticsgC

hapterg21gDruggTherapygWithgMacrolidesgandgMiscellaneousgAnti-

infectivegAgentsgChapterg22gDruggTherapygforgTuberculosisgandgMycobacteriumgaviumg

ComplexgDiseasegChapterg23gDruggTherapygforgViralgInfections

Chapterg24gDruggTherapygforgFungalgInfectionsgChap

terg25gDruggTherapygforgParasiticgInfections



SECTIONg5gDrugsgAffectinggthegCardiovasculargSystem

Chapterg26gDruggTherapygforgHypertensio

ngChapterg27gDruggTherapygforgDysrhythm

ias

Chapterg28gDruggTherapygforgCoronarygHeartgDiseas

egChapterg29gDruggTherapygforgShockgandgHypotens

iongChapterg30gDruggTherapygforgHeartgFailure



SECTIONg6gDrugsgAffectinggthegRespiratorygSystem

Chapterg31gDruggTherapygforgNasalgCongestiongandgCough

, TEST BANK FOR ABRAMS’ CLINICAL DRUG THERAPY
g g g g g g g


RATIONALES FOR NURSING PRACTICE 12TH EDITION
g g g g g g


GERALYN FRANDSEN g
Chapterg32gDruggTherapygtogDecreasegHistaminegEffectsgandgAllergicgResponse

gChapterg33gDruggTherapygforgAsthmagandgBronchoconstriction